PROMISE Registry: PROspective Study on Management of Ischemic Stroke Secondary to mEvo Registry

NCT07746947 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 652

Last updated 2026-08-05

No results posted yet for this study

Summary

Investigators are conducting a real world, observational, prospective, multicenter study to better understand treatment for patients with MeVo and distal vessel occlusions in the U.S post publication of recent MeVO trials.

Conditions

  • Management of Ischemic Stroke
  • Medium Vessel Occlusion

Sponsors & Collaborators

  • phenox Inc.

    collaborator INDUSTRY
  • Indiana University

    lead OTHER

Principal Investigators

  • Kaustubh Limaye, MD, FAHA · Indiana University

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-11
Primary Completion
2029-07-11
Completion
2030-07-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07746947 on ClinicalTrials.gov